- Home
- Products
Ocaliva (Obeticholic Acid)
Ocaliva (Obeticholic Acid)
- Medicine Name: Ocaliva
- Generic Name: Obeticholic Acid
- Dosage Form & Strength: Tablets – 5 mg, 10 mg
- Manufactured By: Intercept Pharmaceuticals, Inc.
Ocaliva (Obeticholic Acid) is an FXR (farnesoid X receptor) agonist prescribed for adults with primary biliary cholangitis (PBC) who either:
- Have not responded adequately to ursodeoxycholic acid (UDCA) after at least 12 months, or
- Are unable to tolerate UDCA.
It is used alone or in combination with UDCA in patients without cirrhosis or with compensated cirrhosis and no evidence of portal hypertension.
Recommended Dosage:
- Initial Dose: 5 mg once daily (with or without food) for the first 3 months.
- Titration: If tolerated and needed, increase to a maximum of 10 mg once daily.
For patients using bile acid binding resins, take Ocaliva at least 4 hours before or after the resin.
Liver Function Monitoring: Use cautiously in patients with cirrhosis. Ocaliva may worsen liver function and lead to hepatic failure. Discontinue if signs of decompensation occur.
Severe Itching (Pruritus): May affect quality of life. Consult your physician if symptoms become intolerable.
Cholesterol Levels: Ocaliva may reduce HDL-C. Monitor lipid profiles periodically.
Pregnancy Risk: May cause harm to an unborn baby. Effective contraception should be used during treatment and for 7 days after.
Breastfeeding: The effect on breast milk is unknown. Avoid breastfeeding during and for 7 days after the last dose.
Required Documents for Import:
- Valid prescription from a licensed medical practitioner
- Patient’s diagnostic reports
- Government-issued ID proof
Order Confirmation:
- Orders are confirmed upon receiving valid documentation and import permit (if applicable)
Availability in India & Internationally: Ocaliva is available through Global Rare Meds for patients, hospitals, and doctors in cities across India including Mumbai, Hyderabad, Delhi, Pune, Bangalore, Ahmedabad, Chennai, and more.
Global Rare Meds also supports availability in Gulf and SAARC countries including UAE, Oman, Saudi Arabia, Nepal, Bangladesh, and Sri Lanka, through authorized legal pathways.
For enquiries:
- Phone/WhatsApp: +91-99675 15602
- Email: info@globalraremeds.com
Global Rare Meds sources Ocaliva and its generic alternatives like Ocanat (Obeticholic Acid) from reliable international and Indian manufacturers.
Fulfillment is managed via our licensed distribution center in Ambernath, Thane District, ensuring compliance and timely delivery to patients across India and globally.
What is the Generic Name for Ocaliva®?
Obeticholic Acid
Who manufactures Ocaliva®?
Intercept Pharmaceuticals, Inc.
Is Ocaliva® FDA approved?
Yes, approved by the FDA on May 27, 2016.
What forms is Ocaliva® supplied in?
Tablets: 5 mg and 10 mg
Where can I get Ocaliva® at the best price in India?
Contact Global Rare Meds for transparent pricing with a valid prescription.
Common side effects of Ocaliva®?
Pruritus, fatigue, abdominal pain, rash, constipation, joint pain, dizziness, and thyroid abnormalities.
What are the storage conditions?
Store at 20°C to 25°C (68°F to 77°F). Permissible range: 15°C to 30°C (59°F to 86°F).
Is it safe to buy Ocaliva® online in India?
Yes, via Global Rare Meds under compliant named-patient supply channels.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
